Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Everything You Wanted to Know About Palliative Care but Were Afraid to Ask
Track: Educational Sessions (CE)
Program Code: 215-L01
Date: Wednesday, December 9, 2009
Time: 2:00 PM to 5:00 PM EST
Location: Venetian D, Level 2
MEETING PLANNING ASSOCIATE:   Click the plus sign to see more detailed information about each speaker.
 Mary Lynn McPherson, PharmD, BCPS, Professor, Vice Chair, and Hospice Consultant Pharmacist, University of Maryland School of Pharmacy
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 Mary Lynn McPherson, PharmD, BCPS, Professor, Vice Chair, and Hospice Consultant Pharmacist, University of Maryland School of Pharmacy
 Jennifer Strickland, PharmD, BCPS, Co-Director of Center for Advancing QOL (LRMC), Lakeland Regional Medical Center - Department of Pharmacy
 Kathryn Walker, PharmD, BCPS, Palliative Care Clinical Pharmacist and Assistant Professor, University of Maryland School of Pharmacy; Union Memorial Hospital
Description
ACPE Activity #204-000-09-215-L01P
3.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Mary Lynn McPherson, PharmD, BCPS, FASHP, Professor and Vice Chair, University of Maryland School of Pharmacy, Baltimore; and Hospice Consultant Pharmacist

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 3:00 p.m.
Pain and Symptom Management
Jennifer Strickland, PharmD, BCPS, Co-Director of Center for Advancing QOL (LRMC), Pain Specialist, and Director of Pharmacy, Lakeland Regional Medical Center, Lakeland, FL

3:00 p.m. – 3:55 p.m.
Opioid Conversion Calculations
Mary Lynn McPherson

3:55 p.m. – 4:50 p.m.
Ethical Issues in Palliative Care Pharmacy
Kathryn Walker, PharmD, BCPS, Palliative Care Clinical Pharmacist and Assistant Professor, University of Maryland School of Pharmacy; Union Memorial Hospital, Baltimore

4:50 p.m. – 5:00 p.m.
Questions, Answers, and Discussion

Learning Objectives:

  • Describe controversial issues related to interventions for symptoms commonly experienced by patients with advanced illness.
  • Describe evidence-based pharmacotherapeutic interventions for the symptoms experienced most commonly by patients with advanced illness.
  • Describe nontraditional roles for pharmacists in caring for patients with advanced illness.
  • Describe reasons why a patient may need to be switched from one opioid to another, one route of administration to another, or both.


Audio Synchronized to PowerPoint
(Code: 215-L01)
Attendee:Free
  
This session is a part of:
Handout Online
View